Quick Answer
Loss of smell on semaglutide is very rare and has no established mechanism. It was not reported as a side effect in STEP clinical trials. If you notice reduced or absent smell during treatment, the more likely explanations are zinc deficiency from eating less, nasal dryness from dehydration, sinus issues, or coincidental causes unrelated to the medication. Try zinc supplementation (15 to 30 mg daily), increase hydration, and use saline nasal spray. If smell changes persist beyond 2 weeks, see an ENT specialist for proper evaluation.
Medical Disclaimer: This article is for informational purposes only. Sudden complete loss of smell, especially with neurological symptoms like confusion or weakness, warrants urgent medical evaluation.
No Established Connection
Loss of smell (anosmia) and reduced smell (hyposmia) were not reported as adverse events in the STEP 1 trial[1] (Wilding et al., NEJM 2021), the pooled STEP 1-3 analysis (Wharton et al., Diabetes, Obesity and Metabolism, 2022), or the SELECT trial[2] (Lincoff et al., NEJM 2023). Across thousands of patients studied in these trials, olfactory changes did not emerge as a signal.
View data table
| Category | Treatment Progress (%) | Detail |
|---|---|---|
| Week 1-2 | 25 | Appetite reduction begins |
| Month 1 | 45 | Nausea subsides, energy improves |
| Month 3 | 70 | Visible weight loss (~5-8%) |
| Month 6 | 85 | Significant results (~10-15%) |
| Month 12 | 95 | Full therapeutic benefit |
A small number of patients in online communities have reported smell changes while taking semaglutide. These anecdotal reports are difficult to interpret because smell changes are common in the general population (affecting approximately 10 to 15% of adults), and correlation during medication use does not establish causation. The timing may be coincidental.
FormBlends takes all patient-reported symptoms seriously while being transparent about what the evidence does and does not show. In the case of smell changes, the evidence does not support a direct connection to semaglutide, but the symptom still deserves evaluation because treatable causes exist.
Zinc Deficiency and Smell
Zinc is essential for the function of olfactory receptors and the regeneration of olfactory neurons in the nasal mucosa. These neurons turn over regularly and require zinc for proper differentiation and function. When zinc stores are depleted, olfactory function declines, producing reduced or altered smell perception.
Get provider-reviewed GLP-1 therapy
Side effects are manageable with the right support. A licensed provider can adjust your dose when you need it.
Start Free Assessment →Semaglutide patients are at risk for zinc deficiency because they eat less food overall. Zinc-rich foods (red meat, shellfish, legumes, nuts, seeds) may be consumed in smaller quantities when appetite is suppressed. Unlike some nutrients, the body does not store large reserves of zinc, so ongoing dietary intake is important. See our metallic taste article for a deeper discussion of zinc and taste/smell function.
If zinc deficiency is contributing to smell changes, supplementation with 15 to 30 mg of zinc daily typically restores olfactory function within 2 to 4 weeks as olfactory neurons regenerate. FormBlends recommends checking zinc levels for patients who report concurrent taste and smell changes, as both point to the same nutritional deficiency.
Dehydration and Nasal Dryness
Smell depends on molecules dissolving in the thin layer of mucus that covers the olfactory epithelium in the upper nasal cavity. When the nasal mucosa is dry, odor molecules cannot dissolve properly, and smell perception decreases. Dehydration reduces mucus production throughout the body, including in the nasal passages.
Semaglutide patients who are not drinking enough water often have dry nasal passages alongside dry mouth and concentrated urine. Increasing fluid intake to 64+ ounces daily and using saline nasal spray (available over the counter) can rehydrate the nasal mucosa and restore normal smell function. This is a simple fix that should be tried before pursuing more complex evaluations. For hydration guidance, see our dehydration guide.
More Likely Causes
Post-viral anosmia. Since 2020, COVID-19 has been the most common cause of sudden smell loss. Even mild or asymptomatic infections can damage olfactory neurons. If you had a respiratory illness (even a mild cold) in the weeks before noticing smell changes, post-viral anosmia is the more likely explanation than semaglutide.
Chronic sinusitis and nasal polyps. Inflammation in the sinuses and nasal passages can physically block odor molecules from reaching the olfactory epithelium. Nasal polyps are benign growths that develop in the nasal passages and sinuses, often causing gradual smell loss. An ENT evaluation can identify these causes.
Aging. Olfactory function naturally declines with age, with measurable decreases starting around age 50. If you are in this age range, smell changes may reflect normal aging rather than medication effects.
Medications. Certain medications can affect smell, including some antibiotics, blood pressure medications, and chemotherapy drugs. If you take multiple medications, review potential olfactory side effects with your pharmacist.
What Community Reports Reveal
r/Semaglutide: "Has anyone lost their sense of smell?"
12 upvotes, 18 comments
A patient reported gradual smell reduction over 2 months on semaglutide. The community response was mixed: a few others reported similar experiences, but the majority had not noticed any smell changes. Several commenters suggested zinc supplementation and COVID testing. The thread highlighted the difficulty of attributing rare symptoms to a medication when many other explanations exist.
Top comment: "Get tested for COVID first. Then try zinc. Loss of smell on semaglutide is not common enough to blame the medication without ruling out other causes."
Clinical gap: Olfactory function has never been formally assessed in GLP-1 receptor agonist trials using standardized smell testing (like the University of Pennsylvania Smell Identification Test). Adding olfactory assessment to future trials would definitively establish or refute any connection between GLP-1 receptor activation and smell function.
When to See an ENT
See an ear, nose, and throat specialist if smell loss persists for more than 2 weeks and is not explained by a cold, allergies, or resolved by zinc supplementation and hydration. The ENT can perform nasal endoscopy to check for polyps, inflammation, or structural issues, and may order imaging (CT of sinuses) if needed.
Seek urgent evaluation if smell loss is sudden and complete (rather than gradual), accompanied by headache or neurological symptoms (weakness, confusion, vision changes), or associated with clear fluid draining from the nose (which could indicate a CSF leak). These presentations suggest causes unrelated to semaglutide that need prompt assessment. FormBlends refers patients to ENT when smell complaints do not respond to nutritional optimization. For related sensory changes, see our taste changes article.
Frequently Asked Questions
Can semaglutide cause loss of smell?
No established connection exists. STEP trials did not report olfactory changes. Isolated community reports are likely coincidental or from zinc deficiency, dehydration, or unrelated causes.
What could cause loss of smell during treatment?
Zinc deficiency from eating less, nasal dryness from dehydration, post-viral anosmia (COVID-19 or other viruses), nasal polyps, chronic sinusitis, or aging.
Should I see an ENT?
Yes, if smell loss persists beyond 2 weeks despite zinc supplementation and adequate hydration. Urgently if sudden, complete, or accompanied by neurological symptoms.
Can zinc deficiency cause loss of smell?
Yes. Zinc is essential for olfactory receptor function. Supplementation (15 to 30 mg daily) typically restores smell within 2 to 4 weeks if deficiency is the cause.
Will my sense of smell come back?
Usually yes, once the underlying cause is addressed. Zinc-related changes reverse with supplementation. Dehydration-related changes resolve with hydration. Post-viral anosmia recovery varies.
Medical References
- Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002. [PubMed | ClinicalTrials.gov | DOI]
- Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. N Engl J Med. 2023;389(24):2221-2232. [PubMed | ClinicalTrials.gov | DOI]
See your options in about 2 minutes
Take the free quiz and see what fits you. Quick, private, and no commitment to continue.
See my options →